Back to Agenda
Oncology Pathways Under Pressure: From CAR-T Access Today to Longevity-Driven Care Tomorrow
Session Chair(s)
Bradley Watts
Vice President, Business Development Executive
Connor, Strong, and Buckelew, United States
By placing CAR-T within a broader trajectory—from breakthrough therapies today to longevity-driven oncology tomorrow—this session challenges stakeholders to rethink how access, value, and sustainability must evolve to keep pace with scientific progress.
Learning Objective : Assess how CAR-T experience has revealed gaps in health technology assessment and reimbursement in the US and Europe; Examine how durable benefit, earlier intervention, and longer oncology horizons challenge current value, outcomes, and sustainability models; Apply multi-stakeholder and patient insights to inform evolving reimbursement and access approaches for potentially curative therapies.
Have an account?